Company Update | PTT Oil and Retail (OR/HOLD/Bt11.90/Target: Bt11.50) We expect OR to report a 1Q26 net profit of Bt2.55b, up 23% qoq. However, core earnings are in a loss position due to controlled retail pricing that does not fully reflect actual costs. This is offset by a substantial stock gain of Bt12.00b. Looking ahead, we anticipate core earnings to recover qoq in 2Q26, supported by a rebound in marketing margins. Meanwhile, impairment risk will remain an overhang on 2026 earnings, particu...
Company Update | Indorama Ventures (IVL TB/BUY/Bt23.80/Target: Bt27.00) IVL’s 1Q26 marks an early-stage recovery, with earnings turning positive supported by inventory gains and improving spreads. However, underlying recovery remains gradual, with a clear step-up expected in 2Q26 as integrated PET spreads rise to about US$260-280/t. US demand and utilisation continue to support margins, while geopolitical tensions provide additional upside to spreads. We maintain BUY with a target price of Bt27....
Company Update | HANA (Thailand) (HANA TB/BUY/Bt30.25/Target: Bt38.00) We expect HANA to report a net profit of Bt145m (-70% yoy, +1% qoq), supported by healthy PCB and the bottoming of the IC semiconductor cycle. AI-related solid-state cooling as a new S-curve in 2H26-2027 and a more positive PMS outlook in 2H26 should support valuation, despite earnings visibility only improving in 2H26. Upgrade to BUY with a higher target price of Bt40.00, as we see strong EPS growth of 30% two-year CAGR over...
Company Update | Bangkok Dusit Medical Services (BDMS TB/BUY/Bt18.50/Target: Bt32.00) BDMS is expected to report 1Q26 profit of Bt3.68b (-15.3% yoy) due to several cost pressures, with flat revenue and margin contraction. 2026 guidance targets 2-4% growth, mainly driven by foreign patients, while Thai demand remains weak. BDMS has limited Middle East exposure (~4%), implying lower downside risk versus peers. Copayment insurance impact is expected to phase in gradually. Maintain BUY with a target...
ZTE's 1Q26 results came in below expectations, primarily driven by a sluggish carrier network business and forex losses. While revenue grew 6.1% yoy to Rmb35.0b, gross margins declined 6.0ppt yoy to 28.3% due to a weak product mix and unfavorable forex impacts on overseas business. Consequently, operating profit declined 13.2% yoy to Rmb1.6b, and net profit plunged 46.6% yoy to Rmb1.3b, missing consensus estimates of Rmb2.1b. Maintain HOLD and keep target price at HK$23.20.
Shuanghuan reported solid 4Q25, in line with expectations. However, 1Q26 numbers are weaker than expected due to flattish EV gear destocking and a worse-than-expected ICE-car gear business. Management expects a recovery in EV sales growth thanks to the overseas market, but ICE-car sales will remain weak. This will be offset by strong construction machinery, smart actuator and CV gear businesses. Management remains confident in achieving its Rmb1.5b share incentive net profit target for 2026. Mai...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.